IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ponoi II Management, LLC

Q4 2021 Holdings

Filed 2022-02-11 | 4 holdings | $55.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$23.0K1,298,90841.8%
Revolution Medicines Inc(RVMD)COM76155X100$17.2K685,01131.3%
Nurix Therapeutics Inc(NRIX)COM67080M103$9.5K327,12317.2%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$5.3K145,4019.7%